ATI LPN
Wong's Essentials of Pediatric Nursing 11th Edition Test Bank
Chapter 25 : The Child with Cancer Questions
Question 1 of 5
The nurse is caring for a child receiving chemotherapy for leukemia. The childs granulocyte count is 600/mm3 and platelet count is 45,000/mm3. What oral care should the nurse recommend for this child?
Correct Answer: B
Rationale: With granulocytes above 500/mm3 and platelets above 40,000/mm3, daily toothbrushing and flossing are safe and effective for oral hygiene. Water rinsing is inadequate, lemon glycerin swabs irritate and dry mucosa, and gauze/
Toothettes are for lower counts.
Question 2 of 5
What immunization should not be given to a child receiving chemotherapy for cancer?
Correct Answer: D
Rationale: MMR, a live virus vaccine, risks severe disease in immunocompromised children receiving chemotherapy. Tetanus, inactivated poliovirus, and DPT are safe but may have reduced efficacy, often delayed until immunosuppression resolves.
Question 3 of 5
What childhood cancer may demonstrate patterns of inheritance that suggest a familial basis?
Correct Answer: B
Rationale: Retinoblastoma is inherited due to mutations in the retinoblastoma gene, promoting abnormal cell growth. Leukemia may involve chromosomal abnormalities like the Philadelphia chromosome, but not familial patterns. Rhabdomyosarcoma and osteogenic sarcoma lack evidence of familial inheritance.
Question 4 of 5
As part of the diagnostic evaluation of a child with cancer, biopsies are important for staging. What statement explains what staging means?
Correct Answer: A
Rationale: Staging describes the extent of cancer at diagnosis, correlating with prognosis. It doesn?t measure cell replacement rates, describe tumor biology (which is classification), or define cancer growth mechanisms, but rather quantifies disease spread for treatment planning.
Question 5 of 5
What statement related to clinical trials developed for pediatric cancers is most accurate?
Correct Answer: C
Rationale: Pediatric cancer clinical trials compare the best current therapy (control group) with potentially better treatments (experimental group). They?re accessible beyond major centers, require consent for all therapies, and are tailored by disease type and stage, not standardized.